
Oxymatrine relieves non-alcoholic fatty liver disease by promoting sirtuin 1/adenosine 5‘-monophosphate-activated protein kinase pathway and peroxisome proliferator activated receptor alpha-mediated hepatic fatty acid oxidation
Published on December 27, 2024
study are available from the corresponding author on reasonable request. Funding This work was supported by the National Natural Science
